Clinical Trials In Oregon
Discover hundreds of clinical trials in Oregon.
Search clinical trials in Oregon by city, condition or phase.
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT03871257
Conditions
Low Grade Glioma
Neurofibromatosis Type 1
Visual Pathway Glioma
Eligibility Criteria
Sex: All
Age: 2 - 21
Healthy Volunteers: Not accepted
Interventions
Carboplatin
Magnetic Resonance Imaging
Quality-of-Life Assessment
Questionnaire Administration
Selumetinib Sulfate
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab
Sponsor:
Replimune Inc.
Location:
Code:
NCT03767348
Conditions
Cancer
Melanoma (Skin)
Mismatch Repair Deficiency
Microsatellite Instability
Non-melanoma Skin Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
RP1
nivolumab
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT04174157
Conditions
Spinal Muscular Atrophy (SMA)
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Prospective observational registry
Zolgensma
A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma
Sponsor:
GlaxoSmithKline
Location:
Code:
NCT06261957
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Salbutamol HFA-134a
Salbutamol HFA-152a
A Trial to Find Out if REGN5678 is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Sponsor:
Regeneron Pharmaceuticals
Location:
Code:
NCT03972657
Conditions
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Clear Cell Renal Cell Carcinoma (ccRCC)
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
REGN5678
Cemiplimab
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
Sponsor:
AbbVie
Location:
Code:
NCT04499248
Conditions
Open-angle Glaucoma
Ocular Hypertension
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AGN-193408 SR
Lumigan
Sham Administration
Lumigan Vehicle
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1
Sponsor:
Sutro Biopharma, Inc.
Location:
Code:
NCT05870748
Conditions
Ovarian Cancer
Epithelial Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Platinum-resistant Ovarian Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Luveltamab tazevibulin
Pegfilgrastim
Gemcitabine
Paclitaxel
Pegylated liposomal doxorubicin
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Sponsor:
University of Kansas Medical Center
Location:
Code:
NCT06425848
Conditions
Heart Failure
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Observational
SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST
Sponsor:
Sarcoma Alliance for Research through Collaboration
Location:
Code:
NCT06208748
Conditions
Gastrointestinal Stromal Tumors
GIST
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bezuclastinib in combination with sunitinib